Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582335 · ClinicalTrials.gov registry record
Identification of New Colorectal Cancer Genes
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 337
- Enrollment target
NCT00582335: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00582335 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 337 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00582335 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 337 participants
- Enrollment target
Study Summary
The purpose of this study is to define new genes for family risks of developing colon cancer.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 337 participants |
| Start Date | 1998-02-10 |
| Est. Completion | 2021-12-17 |
What the finished NCT00582335 record still lists
NCT00582335 is an observational study that tracks outcomes without assigning an intervention. The registered 337 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00582335 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00582335 about?
NCT00582335 is a clinical study titled "Identification of New Colorectal Cancer Genes". The purpose of this study is to define new genes for family risks of developing colon cancer.
What is the current status of trial NCT00582335?
This trial is currently completed. The enrollment target is 337 participants. The study started on 1998-02-10. Estimated completion is 2021-12-17.
Who is sponsoring clinical trial NCT00582335?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03253263 · 338 participants · Phase 2
A Clinical Efficacy and Safety Study of OHB-607 in Preventing Bronchopulmonary Dysplasia in Extremely Premature Infants
- NCT05658731 · 338 participants · NA
Cognitive Outcomes After Brain Substructure-informed Radiation Planning in Pediatric Patients
- NCT06022939 · 338 participants · Phase 3
Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis
- NCT03947385 · 336 participants · Phase 1
Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI